Clinical trials
Phase 3 Seizures trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
147 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 8 |
| 2006 | 11 |
| 2007 | 10 |
| 2008 | 10 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 104 |
| Terminated | 18 |
| Recruiting | 11 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 3 |
| Withdrawn | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| SK Life Science, Inc. | 12 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 11 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 9 |
| GlaxoSmithKline | 8 |
| Eisai Inc. | 7 |
| UCB Pharma | 6 |
| Xenon Pharmaceuticals Inc. | 5 |
| Jazz Pharmaceuticals | 4 |
| Marinus Pharmaceuticals | 4 |
| Novartis Pharmaceuticals | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seizures | 147 |
| Epilepsy | 100 |
| Epilepsies, Partial | 33 |
| Epilepsies, Myoclonic | 11 |
| Lennox Gastaut Syndrome | 11 |
| Epilepsy, Complex Partial | 8 |
| Status Epilepticus | 8 |
| Brain Diseases | 7 |
| Epilepsy, Tonic-Clonic | 7 |
| Epilepsy, Generalized | 6 |
Trials
Showing 26 to 50 of 147. Each trial links to its page on Pharma Observatory.
47 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.